Patent details

EP3781132 Title: APIXABAN FORMULATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3781132
WO Application Number:
US2019027456
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19722333.2
WO Publication Number:
WO2019204193
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
15/04/2019
Grant date:
20/03/2024
EP Publication Date:
24/02/2021
WO Publication Date:
24/10/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/06/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/03/2024
EP B1 Publication Date:
20/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/04/2039
Lapsed By Expiration Date:
Patent Validated Date:
18/07/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
20/03/2024
 
 

 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 & Province Line Road, Princeton, NJ 08543, United States of America (US)

From:
20/03/2024
 
 

 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
17/07/2024
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BADAWY, Sherif, Ibrahim, Farag
Address:
Princeton, NJ 08543-4000, United States of America (US)

2

Name:
STEVENS, Timothy, D.
Address:
Princeton, NJ 08543-4000, United States of America (US)

3

Name:
KUNTZ, Daniel
Address:
Princeton, NJ 08543-4000, United States of America (US)

4

Name:
WAYBRANT, Brett
Address:
Princeton, NJ 08543-4000, United States of America (US)

Priority

Priority Patent Number:
201862658175 P
Priority Date:
16/04/2018
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/16; A61K 31/4545; A61P 7/02;

Publication

Bulletin

1

Bulletin Heading:
VB1
Journal edition number:
04/25
Publication date:
24/01/2025
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

2

Bulletin Heading:
EP3
Journal edition number:
30/24
Publication date:
24/07/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
12/24
Publication date:
20/03/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202504
Publication date:
22/01/2025
Description:
Opposition procedure started

2

Issue number:
202414
Publication date:
03/04/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202412
Publication date:
20/03/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/04/2026
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
17/03/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
17/07/2024 Outgoing Correspondence Letter no formal defects 1 PDF /5/7/3/1/8/0800981375/docs/ep19722333.2_1_612506l271.pdf
06/06/2024 Claims First filed claims 2 PDF /5/7/3/1/8/0800981375/docs/ep19722333.2_0_claims20240606114515806.pdf